COVID-19: A Catalyst for Change in Government-Industry Partnership
How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
Crisis or crossroads? Key account management post-COVID
Miranda Wheatley Price from Rubica calls for a dynamic response to the current challenge as she explores the future for key account management post-COVID. One...
From HIV to COVID-19: Charting the path of patient power
Patient power has evolved considerably since it was born to represent the voiceless during the 1980s HIV/AIDS crisis. Will COVID-19 provide the movement with...
The ABPI Code & Virtual Promotional Meetings
As the pharma industry looks to virtual meetings and teams work remotely, what considerations are there around the ABPI Code and virtual promotional meetings? Whilst...
Complex and challenging: Unlocking motor neurone disease
Motor neurone disease is a complex condition making the search for treatments a challenge, but work is ongoing to improve people’s lives. Motor neurone disease...
Getting focused on your local integrated care system
It’s essential that pharma professionals have a detailed understanding of their local Integrated Care System (ICS) to best focus their time in the new...
It’s all in the mind(set): digital transformation in pharma
The importance of mindset and company culture to enable digital transformation in pharma. Top 5 Takeaways Start with defining and understanding the traditional roadblocks of...
Reputation control: changing perceptions of pharma
Amanda Barrel investigates pharma’s reputation, self-regulation, compliance and how pharma can change perceptions of the work it does. Top 5 Takeaways
1 Only 57% of people...
What’s the point…of difference? Partnership working pharma and the NHS
Barriers to partnership working are breaking, it’s time for pharma to build on its differences to be more than a supplier. James Roach and...
Looking for a breakthrough in Parkinson’s research
Will recent investments and developments offer hope for people living with Parkinson’s? Pf explores the condition and work happening to find a breakthrough in...
Latest articles
Merck discontinues development of its COVID-19 vaccines
Merck, known as MSD outside the United States and Canada, has announced that the company is discontinuing development of its two COVID-19 vaccine candidates,...
COVID-19 vaccination programme ramps up with 30 new centres
More than 30 new NHS Vaccine Centres will start delivering COVID-19 jabs this week as the health service continues to accelerate the biggest immunisation...
Isle of Man set to become world-leading exporter of medicinal cannabis
The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
JCVI updates priority list for COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
Isle of Man set to become world-leading exporter of medicinal cannabis
The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...